Home/Filings/4/0001209191-21-037894
4//SEC Filing

Hanley David C. 4

Accession 0001209191-21-037894

CIK 0001811063other

Filed

Jun 2, 8:00 PM ET

Accepted

Jun 3, 6:36 PM ET

Size

11.3 KB

Accession

0001209191-21-037894

Insider Transaction Report

Form 4
Period: 2021-06-01
Hanley David C.
CHIEF TECHNICAL OPERATIONS
Transactions
  • Award

    Stock Option (Right to Buy)

    2021-06-01+250,000250,000 total
    Exercise: $13.60Exp: 2031-05-31Class A Common Stock (250,000 underlying)
  • Award

    Stock Option (Right to Buy)

    2021-06-01+187,500187,500 total
    Exercise: $13.60Exp: 2031-05-31Class A Common Stock (187,500 underlying)
Footnotes (2)
  • [F1]25% of the shares subject to the option vest on June 1, 2022 and 1/48 of the total number of shares subject to the option vest each month thereafter, subject to the Reporting Person's continuous service through each applicable vesting date.
  • [F2]The shares subject to the Options will vest based on the satisfaction of both time-based and performance-based vesting criteria.

Issuer

Nuvation Bio Inc.

CIK 0001811063

Entity typeother

Related Parties

1
  • filerCIK 0001865826

Filing Metadata

Form type
4
Filed
Jun 2, 8:00 PM ET
Accepted
Jun 3, 6:36 PM ET
Size
11.3 KB